(Total Views: 767)
Posted On: 09/22/2021 9:43:54 PM
Post# of 155000
I saw a reference on YMB to a new investor contact at the bottom of a recent PR, so I did some investigating. This is what I found.
Previous PRs approximately through July ended with the following:
CONTACTS
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com
The 8/13 PR about the FDA guidance for HIV BLA ended as follows:
CONTACTS
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com
Media:
Dan Zacchei / Joe Germani
Sloane & Company
dzacchei@sloanepr.com / jgermani@sloanepr.com
They added Sloane as a media contact.
The 9/22 PR about clearance from Brazil's FDA and the 2 PRs since then ended as follows:
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com
OR
Mike Verrechia / Bill Dooley, 800-662-5200
Morrow Sodali
cydy@info.morrowsodali.com
Media:
Dan Zacchei / Joe Germani
Sloane & Company
dzacchei@sloanepr.com / jgermani@sloanepr.com
https://www.cytodyn.com/newsroom/press-releas...-anvisa-to
From a brief look at their website, the addition of Morrow Sodali as investor contacts appears to be quite a step up (they look like heavy hitters). Hopefully this just shows how management is preparing for some great PRs that we believe are just around the corner. They also have M&A expertise. Nice move by NP to get this working in advance.
The following is from Morrow Sodali's website:
https://morrowsodali.com/
MORROW SODALI IS A LEADING PROVIDER OF STRATEGIC ADVICE AND SHAREHOLDER SERVICES TO CORPORATE CLIENTS AROUND THE WORLD.
The firm provides corporate boards and executives with strategic advice and services relating to corporate governance, shareholder and bondholder communication and engagement, capital markets intelligence, proxy solicitation, shareholder activism and mergers and acquisitions.
From headquarters in New York and London, and offices and partners in major capital markets, Morrow Sodali serves more than 700 corporate clients in 80+ countries, including many of the world’s largest multinational corporations. In addition to listed and private companies, its clients include financial institutions, mutual funds, ETFs, stock exchanges and membership associations.
Previous PRs approximately through July ended with the following:
CONTACTS
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com
The 8/13 PR about the FDA guidance for HIV BLA ended as follows:
CONTACTS
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com
Media:
Dan Zacchei / Joe Germani
Sloane & Company
dzacchei@sloanepr.com / jgermani@sloanepr.com
They added Sloane as a media contact.
The 9/22 PR about clearance from Brazil's FDA and the 2 PRs since then ended as follows:
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com
OR
Mike Verrechia / Bill Dooley, 800-662-5200
Morrow Sodali
cydy@info.morrowsodali.com
Media:
Dan Zacchei / Joe Germani
Sloane & Company
dzacchei@sloanepr.com / jgermani@sloanepr.com
https://www.cytodyn.com/newsroom/press-releas...-anvisa-to
From a brief look at their website, the addition of Morrow Sodali as investor contacts appears to be quite a step up (they look like heavy hitters). Hopefully this just shows how management is preparing for some great PRs that we believe are just around the corner. They also have M&A expertise. Nice move by NP to get this working in advance.
The following is from Morrow Sodali's website:
https://morrowsodali.com/
MORROW SODALI IS A LEADING PROVIDER OF STRATEGIC ADVICE AND SHAREHOLDER SERVICES TO CORPORATE CLIENTS AROUND THE WORLD.
The firm provides corporate boards and executives with strategic advice and services relating to corporate governance, shareholder and bondholder communication and engagement, capital markets intelligence, proxy solicitation, shareholder activism and mergers and acquisitions.
From headquarters in New York and London, and offices and partners in major capital markets, Morrow Sodali serves more than 700 corporate clients in 80+ countries, including many of the world’s largest multinational corporations. In addition to listed and private companies, its clients include financial institutions, mutual funds, ETFs, stock exchanges and membership associations.
(22)
(0)
